COVID-19 vaccination coverage and intent among women aged 18-49 years by pregnancy status, United States, April-November 2021.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
30 07 2022
Historique:
received: 25 03 2022
revised: 06 05 2022
accepted: 01 06 2022
pubmed: 21 6 2022
medline: 22 7 2022
entrez: 20 6 2022
Statut: ppublish

Résumé

Pregnant and postpartum women are at increased risk for severe illness from COVID-19. We assessed COVID-19 vaccination coverage, intent, and attitudes among women of reproductive age overall and by pregnancy status in the United States. Data from the National Immunization Survey Adult COVID Module collected during April 22-November 27, 2021, were analyzed to assess COVID-19 vaccination (receipt of ≥1 dose), intent for vaccination, and attitudes towards vaccination among women aged 18-49 years overall and by pregnancy status (trying to get pregnant, currently pregnant, breastfeeding, and not trying to get pregnant or currently pregnant or breastfeeding). Logistic regression and predictive marginals were used to generate unadjusted and adjusted prevalence ratios (PRs and aPRs). Trend analyses were conducted to assess monthly changes in vaccination and intent. Our analyses included 110,925 women aged 18-49 years. COVID-19 vaccination coverage (≥1 dose) was 63.2% overall (range from 53.3% in HHS Region 4 to 76.5% in HHS Region 1). Vaccination coverage was lowest among pregnant women (45.1%), followed by women who were trying to get pregnant (49.5%), women who were breastfeeding (51.5%), and all other women (64.9%). Non-Hispanic (NH) Black women who were pregnant or breastfeeding had significantly lower vaccination coverage (aPR: 0.74 and 0.66, respectively) than NH White women. Our findings are consistent with other studies showing lower vaccination coverage among pregnant individuals, with substantially lower vaccination coverage among NH Black women who are pregnant or breastfeeding. Given the overlapping and disproportionate risks of COVID-19 and maternal mortality among Black women, it is critical that COVID-19 vaccination be strongly recommended for these populations and all women of reproductive age. Healthcare and public health providers may take advantage of every opportunity to encourage vaccination and enlist the assistance of community leaders, particularly in communities with low vaccination coverage.

Sections du résumé

BACKGROUND
Pregnant and postpartum women are at increased risk for severe illness from COVID-19. We assessed COVID-19 vaccination coverage, intent, and attitudes among women of reproductive age overall and by pregnancy status in the United States.
METHODS
Data from the National Immunization Survey Adult COVID Module collected during April 22-November 27, 2021, were analyzed to assess COVID-19 vaccination (receipt of ≥1 dose), intent for vaccination, and attitudes towards vaccination among women aged 18-49 years overall and by pregnancy status (trying to get pregnant, currently pregnant, breastfeeding, and not trying to get pregnant or currently pregnant or breastfeeding). Logistic regression and predictive marginals were used to generate unadjusted and adjusted prevalence ratios (PRs and aPRs). Trend analyses were conducted to assess monthly changes in vaccination and intent.
RESULTS
Our analyses included 110,925 women aged 18-49 years. COVID-19 vaccination coverage (≥1 dose) was 63.2% overall (range from 53.3% in HHS Region 4 to 76.5% in HHS Region 1). Vaccination coverage was lowest among pregnant women (45.1%), followed by women who were trying to get pregnant (49.5%), women who were breastfeeding (51.5%), and all other women (64.9%). Non-Hispanic (NH) Black women who were pregnant or breastfeeding had significantly lower vaccination coverage (aPR: 0.74 and 0.66, respectively) than NH White women.
DISCUSSION
Our findings are consistent with other studies showing lower vaccination coverage among pregnant individuals, with substantially lower vaccination coverage among NH Black women who are pregnant or breastfeeding. Given the overlapping and disproportionate risks of COVID-19 and maternal mortality among Black women, it is critical that COVID-19 vaccination be strongly recommended for these populations and all women of reproductive age. Healthcare and public health providers may take advantage of every opportunity to encourage vaccination and enlist the assistance of community leaders, particularly in communities with low vaccination coverage.

Identifiants

pubmed: 35725781
pii: S0264-410X(22)00779-4
doi: 10.1016/j.vaccine.2022.06.029
pmc: PMC9189004
pii:
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4554-4563

Informations de copyright

Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1641-1647
pubmed: 33151921
Public Health Rep. 2015 Nov-Dec;130(6):573-95
pubmed: 26556929
Am J Obstet Gynecol. 2021 Sep;225(3):303.e1-303.e17
pubmed: 33775692
J Consult Clin Psychol. 2018 Feb;86(2):140-157
pubmed: 29265832
MMWR Morb Mortal Wkly Rep. 2022 Jan 07;71(1):26-30
pubmed: 34990445
MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1635-1640
pubmed: 33151917
Int J Gynaecol Obstet. 2021 Aug;154(2):291-296
pubmed: 33872386
Eur J Epidemiol. 2021 Feb;36(2):197-211
pubmed: 33649879
Health Promot Pract. 2021 Sep;22(5):611-615
pubmed: 33966471
Acad Pediatr. 2021 May-Jun;21(4S):S9-S16
pubmed: 33958099
CMAJ. 2021 Apr 19;193(16):E540-E548
pubmed: 33741725
MMWR Morb Mortal Wkly Rep. 2020 Oct 02;69(39):1391-1397
pubmed: 33001873
BMC Public Health. 2021 Jun 17;21(1):1166
pubmed: 34140009
Am J Perinatol. 2022 Jan;39(1):75-83
pubmed: 34598291
Am J Infect Control. 2014 Jul;42(7):763-9
pubmed: 24799120
Obstet Gynecol. 2022 Jan 1;139(1):107-109
pubmed: 34644272
Nat Med. 2021 Oct;27(10):1693-1695
pubmed: 34493859
MMWR Morb Mortal Wkly Rep. 2021 Nov 26;70(47):1646-1648
pubmed: 34818319
N Engl J Med. 2021 Jun 17;384(24):2273-2282
pubmed: 33882218
MMWR Morb Mortal Wkly Rep. 2021 Jun 18;70(24):895-899
pubmed: 34138834
Am J Obstet Gynecol MFM. 2021 Nov;3(6):100467
pubmed: 34425297
Am J Public Health. 2015 Oct;105(10):1998-2004
pubmed: 25790386
Can Commun Dis Rep. 2020 Apr 02;46(4):93-97
pubmed: 32281992
JAMA. 2021 Aug 24;326(8):728-735
pubmed: 34251417
JAMA. 2021 Oct 26;326(16):1629-1631
pubmed: 34495304
Am J Public Health. 2011 Jul;101(7):1252-5
pubmed: 21566026
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1723-1730
pubmed: 34914669
BMJ Open. 2020 Aug 11;10(8):e039299
pubmed: 32784263
BMJ. 2020 Sep 1;370:m3320
pubmed: 32873575
N Engl J Med. 2021 Oct 14;385(16):1533-1535
pubmed: 34496196
MMWR Morb Mortal Wkly Rep. 2021 Apr 16;70(15):566-569
pubmed: 33857062

Auteurs

Hilda Razzaghi (H)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: HRazzaghi@cdc.gov.

David Yankey (D)

Oak Ridge Institute for Science and Education, United States.

Kushagra Vashist (K)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States; Oak Ridge Institute for Science and Education, United States.

Peng-Jun Lu (PJ)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Jennifer L Kriss (JL)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Kimberly H Nguyen (KH)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

James Lee (J)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Sascha Ellington (S)

Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Center for Disease Control and Prevention, United States.

Kara Polen (K)

Division of Birth Defects and Infant Disorders, National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Kimberly Bonner (K)

Epidemic Intelligence Service, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Tara C Jatlaoui (TC)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Elisabeth Wilhelm (E)

Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Dana Meaney-Delman (D)

Division of Birth Defects and Infant Disorders, National Center for Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, United States.

James A Singleton (JA)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH